Test Code TTBS Testosterone, Total and Bioavailable, Serum
Test Down Notes
Effective August 22, 2024: This test is temporarily unavailable due to analytic issues. The downtime is expected to be >30 days. Order FFTST as an alternative. See test notification here.
Ordering Guidance
This is the preferred second-level test for suspected increases or decreases in physiologically active testosterone.
Necessary Information
Patient's age and sex are required.
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Useful For
Recommended second-level test for suspected increases or decreases in physiologically active testosterone:
-Assessment of androgen status in cases with suspected or known sex hormone-binding globulin binding abnormalities
-Assessment of functional circulating testosterone in early pubertal boys and older men
-Assessment of functional circulating testosterone in women with symptoms or signs of hyperandrogenism but normal total testosterone levels
-Monitoring of testosterone therapy or antiandrogen therapy in older men and in females
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
BATS | Testosterone, Bioavailable, S | No | Yes |
TTST | Testosterone, Total, S | Yes | Yes |
Method Name
TTST: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
BATS: Differential Precipitation/Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Testosterone, Total and Bioavail, SSpecimen Type
Serum RedSpecimen Minimum Volume
0.6 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 14 days | |
Frozen | 60 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | Reject |
Gross icterus | OK |
Reference Values
TESTOSTERONE, TOTAL:
Males
0-5 months: 75-400 ng/dL
6 months-9 years: <7-20 ng/dL
10-11 years: <7-130 ng/dL
12-13 years: <7-800 ng/dL
14 years: <7-1,200 ng/dL
15-16 years: 100-1,200 ng/dL
17-18 years: 300-1,200 ng/dL
≥19 years: 240-950 ng/dL
Tanner Stages*
I (prepubertal): <7-20
II: 8-66
III: 26-800
IV: 85-1,200
V (young adult): 300-950
Females
0-5 months: 20-80 ng/dL
6 months-9 years: <7-20 ng/dL
10-11 years: <7-44 ng/dL
12-16 years: <7-75 ng/dL
17-18 years: 20-75 ng/dL
≥19 years: 8-60 ng/dL
Tanner Stages*
I (prepubertal): <7-20
II: <7-47
III: 17-75
IV: 20-75
V (young adult): 12-60
*Puberty onset (transition from Tanner stage I to Tanner stage II) occurs for boys at a median age of 11.5 (±2) years and for girls at a median age of 10.5 (±2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African American girls. For boys, there is no definite proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage V (young adult) should be reached by age 18.
TESTOSTERONE, BIOAVAILABLE:
Males
≤19 years: Not established
20-29 years: 83-257 ng/dL
30-39 years: 72-235 ng/dL
40-49 years: 61-213 ng/dL
50-59 years: 50-190 ng/dL
60-69 years: 40-168 ng/dL
≥70 years: Not established
Females (non-oophorectomized)
≤19 years: not established
20-50 years (on oral estrogen): 0.80-4.0 ng/dL
20-50 years (not on oral estrogen): 0.80-10 ng/dL
>50 years: Not established
Day(s) Performed
Monday through Friday
Report Available
2 to 5 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
84403
84410
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
TTBS | Testosterone, Total and Bioavail, S | 58716-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
82978 | Testosterone, Bioavailable, S | 2990-0 |
8533 | Testosterone, Total, S | 2986-8 |